Your browser doesn't support javascript.
loading
NALCN is a potential biomarker and therapeutic target in human cancers.
He, Jian; Xu, Jie; Chang, Zhiwei; Yan, Jiaqin; Zhang, Limin; Qin, Yanru.
Afiliação
  • He J; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Xu J; School of Public Health, Xinxiang Medical University, Xinxiang, China.
  • Chang Z; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Yan J; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Zhang L; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Qin Y; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Front Genet ; 14: 1164707, 2023.
Article em En | MEDLINE | ID: mdl-37152978
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Front Genet Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Front Genet Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China